Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: A review

Research output: Contribution to journalReview articlepeer-review

Abstract

Open retroperitoneal lymph node dissection (RPLND) is the gold standard for surgical management of the retroperitoneum in patients with testicular cancer, and is associated with excellent oncologic outcomes and significant morbidity including length of stay. Minimally invasive RPLND, starting with laparoscopic retroperitoneal lymph node dissection in 1992 and now robotic retroperitoneal lymph node dissection in 2006, endeavor to decrease the morbidity of open RPLND while maintaining excellent oncologic outcomes. This review surveys the literature regarding both primary and post-chemotherapy robotic RPLND, emphasizing that while early outcomes are promising, much work needs to be done before widespread use of this technique is implemented.

Original languageEnglish (US)
Pages (from-to)949-958
Number of pages10
JournalTranslational Andrology and Urology
Volume9
Issue number2
DOIs
StatePublished - Apr 1 2020

Keywords

  • Post-chemotherapy
  • Retroperitoneal lymph node dissection
  • Robotic
  • Testicular cancer

ASJC Scopus subject areas

  • Reproductive Medicine
  • Urology

Fingerprint Dive into the research topics of 'Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: A review'. Together they form a unique fingerprint.

Cite this